Artigo de peri??dico
Poly(3-hydroxi-butyrate-co-3-hydroxy-valerate) (PHB-HV) microparticles loaded with holmium acetylacetonate as potential contrast agents for magnetic resonance images
Registro en:
1178-2013
14
10.2147/IJN.S191274
79.871
85.67
Autor
AZEVEDO, MARIANGELA de B.M. de
MELO, VITOR H.S.
SOARES, CARLOS R.J.
GAMARRA, LIONEL F.
BARROS, CAIO H.N.
TASIC, LJUBICA
Resumen
Introduction: Biodegradable polymers that contain radioactive isotopes such as Holmium 166
have potential applications as beta particle emitters in tumor tissues. Also, Ho(III) is paramagnetic,
which makes it suitable as a contrast agent for magnetic resonance (MR) images.
Methods: Holmium acetylacetonate (Ho(acac)3) loaded poly(3-hydroxy-butyrate-co-3-
hydroxy-valerate) microspheres, with 5% or 8% of 3-hydroxy-valerate (HV), were prepared
by emulsification/evaporation process within 20???53 ??m size. Microspheres characterization
was done using scanning electron microscopy, energy-dispersive X-ray, and infrared spectroscopies.
The release of holmium(III) in sodium phosphate buffer (pH 7.4) was followed for 9
days with inductively coupled plasma. Finally, T2 and T2* magnetic resonance images (MRI)
were acquired and compared with the MRI of the inclusion complex of holmium acetylacetonate
in some ??-cyclodextrins.
Results: Holmium acetylacetonate loading, evaluated by thermogravimetry, was up to 20 times
higher for copolymer with 5% of HV. It was shown that microspheres loaded with Ho(acac)3
exhibited an accumulation of Ho(III) on their surfaces but were stable over time, as no expressive
release of holmium(III) was detected in 9-day exposition to sodium phosphate buffer. Holmium
acetylacetonate in both microspheres or inclusion complexes was very efficient in obtaining T2
and T2* weighted images in magnetic resonance, thus, might be used as contrast agents.
Conclusion: This is the first description of the use of inclusion complexes of holmium
acetylacetonate in biodegradable polymers as contrast agents. New investigations are underway
to evaluate the resistance of PHB-HV polymer microparticles to nuclear activation to
assess their potential for use as radiopharmaceuticals for the treatment of liver cancer. Conselho Nacional de Desenvolvimento Cient??fico e Tecnol??gico (CNPq) Funda????o de Amparo ?? Pesquisa do Estado de S??o Paulo (FAPESP) CNPq: DT306980/2015-0; DT310247/2013-6; DT310227/2010-0; 560423/2010-1; 550598/2010-3; DT 315236/2018-3 FAPESP: 15/26058-0